Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Biomedicines
|
August 25, 2017
Toward the Selection of Cell Targeting Aptamers with Extended Biological Functionalities to Facilitate Endosomal Escape of Cargoes
Kwaku D Tawiah, David Porciani, Donald H Burke
Frontiers in Molecular Biosciences
|
June 1, 2022
Editorial: Molecular Insights Into Ligand-Receptor Interactions on the Cell Surface
Laura Marchetti, David Porciani, Stefania Mitola, et al.
Molecular Therapy. Nucleic Acids
|
February 10, 2022
Cancer immunomodulation using bispecific aptamers
Brian J Thomas, David Porciani, Donald H Burke
Analytical Chemistry
|
December 21, 2023
Fluorescence Correlation Spectroscopy as a Versatile Method to Define Aptamer-Protein Interactions with Single-Molecule Sensitivity
David Porciani, Manuela Maria Alampi, Stefania Abbruzzetti, et al.
Nucleic Acid Therapeutics
|
April 22, 2022
Aptamers Targeting Hallmark Proteins of Neurodegeneration
Niloufar Mollasalehi, Liberty Francois-Moutal, David Porciani, et al.
Molecular Therapy. Nucleic Acids
|
January 30, 2014
Two interconvertible folds modulate the activity of a DNA aptamer against transferrin receptor
David Porciani, Giovanni Signore, Laura Marchetti, et al.
Nucleic Acid Therapeutics
|
May 16, 2024
Multiplexed <i>In Vivo</i> Screening Using Barcoded Aptamer Technology to Identify Oligonucleotide-Based Targeting Reagents
Brian J Thomas, Caitlyn Guldenpfennig, Mark A Daniels, et al.
ACS Synthetic Biology
|
May 27, 2017
A Fluorescent Split Aptamer for Visualizing RNA-RNA Assembly In Vivo
Khalid K Alam, Kwaku D Tawiah, Matthew F Lichte, et al.
Molecular Therapy. Nucleic Acids
|
April 29, 2015
Aptamer-Mediated Codelivery of Doxorubicin and NF-κB Decoy Enhances Chemosensitivity of Pancreatic Tumor Cells
David Porciani, Lorena Tedeschi, Laura Marchetti, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 15, 2023
Valency and affinity control of aptamer-conjugated nanoparticles for selective cancer cell targeting
Laura Woythe, David Porciani, Tessa Harzing, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Biomedicines
|
August 25, 2017
Toward the Selection of Cell Targeting Aptamers with Extended Biological Functionalities to Facilitate Endosomal Escape of Cargoes
Kwaku D Tawiah, David Porciani, Donald H Burke
Frontiers in Molecular Biosciences
|
June 1, 2022
Editorial: Molecular Insights Into Ligand-Receptor Interactions on the Cell Surface
Laura Marchetti, David Porciani, Stefania Mitola, et al.
Molecular Therapy. Nucleic Acids
|
February 10, 2022
Cancer immunomodulation using bispecific aptamers
Brian J Thomas, David Porciani, Donald H Burke
Analytical Chemistry
|
December 21, 2023
Fluorescence Correlation Spectroscopy as a Versatile Method to Define Aptamer-Protein Interactions with Single-Molecule Sensitivity
David Porciani, Manuela Maria Alampi, Stefania Abbruzzetti, et al.
Nucleic Acid Therapeutics
|
April 22, 2022
Aptamers Targeting Hallmark Proteins of Neurodegeneration
Niloufar Mollasalehi, Liberty Francois-Moutal, David Porciani, et al.
Molecular Therapy. Nucleic Acids
|
January 30, 2014
Two interconvertible folds modulate the activity of a DNA aptamer against transferrin receptor
David Porciani, Giovanni Signore, Laura Marchetti, et al.
Nucleic Acid Therapeutics
|
May 16, 2024
Multiplexed <i>In Vivo</i> Screening Using Barcoded Aptamer Technology to Identify Oligonucleotide-Based Targeting Reagents
Brian J Thomas, Caitlyn Guldenpfennig, Mark A Daniels, et al.
ACS Synthetic Biology
|
May 27, 2017
A Fluorescent Split Aptamer for Visualizing RNA-RNA Assembly In Vivo
Khalid K Alam, Kwaku D Tawiah, Matthew F Lichte, et al.
Molecular Therapy. Nucleic Acids
|
April 29, 2015
Aptamer-Mediated Codelivery of Doxorubicin and NF-κB Decoy Enhances Chemosensitivity of Pancreatic Tumor Cells
David Porciani, Lorena Tedeschi, Laura Marchetti, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 15, 2023
Valency and affinity control of aptamer-conjugated nanoparticles for selective cancer cell targeting
Laura Woythe, David Porciani, Tessa Harzing, et al.
Page
of 2